Biogen Files New Drug Application for Aducanumab in Japan

Go back to Biogen Files New Drug Application for Aducanumab in Japan
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 214.35 --0 (-0%)
Previous Close $214.35    52 Week High $333.65 
Open $214.35    52 Week Low $223.02 
Day High $214.35    P/E 27.45 
Day Low $214.35    EPS $7.81 
Volume 86